US website

First part of the presentation provides brief introduction of company MEDICEM, followed by overview of DILAPAN-S and IOL (induction of labour) market. Second part offers you an example of 2022 European communication strategy, incl. unmet needs and DILAPAN-S key benefits.

Join us and stay informed

Don’t miss out on DILAPAN-S news, clinical updates, or information-dense podcasts and webinars—subscribe to our newsletter.